Concepedia

Nithya Thambi

NT

4

Publications

292

Citations

4

H-Index

2015

Active since

Affiliations

Regeneron (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Nithya Thambi is an author at Regeneron (United States) specializing in vaccination, virology, and vaccine development.

Top concepts

Publications per year

2015–2022

4

Publications

4

Bispecific Antibodies and Antibody–Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs

Julian Andreev, Nithya Thambi, Andrés E. Perez Bay et al. · Molecular Cancer Therapeutics · 2017 · 161 citations

Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates

Morgan A. Monslow, Sayda M. Elbashir, Nicole Sullivan et al. · Vaccine · 2020 · 70 citations

, , +7

Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer

Frank Kuhnert, Guoying Chen, Sandra Coetzee et al. · Cancer Research · 2015 · 48 citations · Full text

Single cell multi-omic reference atlases of non-human primate immune tissues reveals CD102 as a biomarker for long-lived plasma cells

Ryan P. Staupe, Kenneth E. Lodge, Nithya Thambi et al. · Communications Biology · 2022 · 13 citations · Full text

Rows per page

1–4 of 4